A highly sensitive qualitative immunoassay to detect the presence of antibodies (IgG and IgM) directed against Human Immunodeficiency Virus type 1 (HIV-1) and type 2 (HIV-2) in a serum sample. This test is used as an initial screening test to detect infection, as these antibodies typically appear within 3-12 weeks of exposure to the virus (window period).